Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
66.50    0.50 (0.76%)
Bid:
65.00
Ask:
68.00
Spread: 3.00 (4.615%)
Market Cap: £58.57m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Board Update

14 Jun 2022 07:00

RNS Number : 7232O
Calnex Solutions PLC
14 June 2022
 

14 June 2022

Calnex Solutions plc

("Calnex" or the "Company")

Board Update

 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications sector, announces that following nine years as Chair of the Board of Calnex, George Elliott has taken the decision to retire from his position on the Board of Directors and will not seek re-election at the Company's 2022 AGM. The Company is pleased to confirm that current Non-Executive Director, Stephen Davidson, has been appointed as Chair Designate and will succeed George at the conclusion of the AGM on 17 August 2022.

 

Stephen Davidson joined the Board of Calnex in January 2022 and is an accomplished director of both public and private companies, with more than 20 years' PLC-board experience. He has previously acted as Chair at AIM-traded companies Actual Experience plc, RBG Holdings plc and Jaywing plc and at JSE-listed Datatec plc.

 

George Elliott, Chair of Calnex, commented, "When I joined Tommy and the team in 2013 it was evident to me that the future for Calnex was an exciting one. It has been an honour to help guide the business through its subsequent growth and journey onto the public markets. I am confident there is a strong Board and management team in place and with its outstanding customer base, the ongoing transition of the telecoms industry to 5G and the growth in cloud computing, the future for Calnex is brighter than ever."

 

Tommy Cook, CEO of Calnex, commented, "George has been a huge support to me over the past nine years and I and the whole Company thank him for his service and wish him all the very best. Our new Directors, Stephen and Margaret Rice-Jones who joined us in January, have quickly become valued colleagues and we have benefitted from their extensive experience and knowledge. I look forward to continuing to work with them both and the wider Board to drive Calnex forward."

 

For more information, please contact:

 

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cenkos Securities plc - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

Alma PR

+ 44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli

 

 

Overview of Calnex

 

Calnex Solutions designs, produces and markets test and measurement instrumentation and solutions for the telecoms and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enabling its customers to validate the performance of the critical infrastructure associated with telecoms and cloud computing networks and the applications that run on it.

 

To date, Calnex has secured and delivered orders to over 680 customer sites in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distribution capability. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKNBKKBKBKAD
Date   Source Headline
17th Apr 20077:01 amRNSUpdate on Possible Offer
11th Apr 200710:41 amRNSRule 38 Calyx Group plc
5th Apr 20079:15 amRNSNotice of Results
15th Mar 20072:26 pmRNSRule 8.3- Calyx Group plc
15th Mar 200710:30 amRNSRule 8.1 Calyx Group plc
13th Mar 20073:15 pmRNSShare Price Movement
8th Feb 20072:33 pmRNSIssue of Equity
27th Dec 20067:00 amRNSIEX Notice
22nd Dec 200611:25 amRNSTotal Voting Rights
19th Dec 20063:46 pmRNSIssue of Shares
15th Dec 20067:58 amRNSShare disposal
14th Dec 20065:08 pmRNSHolding(s) in Company
12th Dec 20068:48 amRNSChange to earn outs
12th Dec 20068:00 amRNSAcquisition & Trading Update
1st Nov 20067:00 amRNSShare Options
25th Sep 20067:03 amRNSInterim Results
27th Jul 20067:00 amRNSDirectorate Change
6th Jul 20067:00 amRNSIEX Notice
30th Jun 20063:58 pmRNSIssue of Equity
29th Jun 20067:01 amRNSAppt of Non-Exec Directors
12th Jun 200612:37 pmRNSNew IEX Admission
12th Jun 20068:00 amRNSAcquisitions & Placing
12th Jun 20067:00 amRNSIEX Notice
9th Jun 200611:45 amRNSResult of AGM and EGM
7th Jun 20068:47 amRNSSch 1 Update - Calyx Group
22nd May 20063:15 pmRNSIEX Schedule One
19th May 20068:56 amRNSSch 1 - Calyx Group
17th May 20067:02 amRNSDisposal
17th May 20067:02 amRNSAcquisition,Admission,Placing
6th Mar 20067:02 amRNSFinal Results
1st Mar 20062:02 pmRNSAcquisition
19th Jan 20067:01 amRNSBT Agreement
26th Oct 20057:00 amRNSUK Acquisition
20th Oct 20054:08 pmRNSAcquisition
30th Aug 20057:02 amRNSMaiden Interim Results
11th Jul 20057:00 amRNSAcquisition & Trading Update
9th Jun 20053:16 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.